Clinical Trial Update: A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating gemcitabine and cisplatin/carboplatin with erlotinib in nasopharyngeal cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Nasopharyngeal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-08-10